Vanberra Signal

Medimaps Group

Curated by Signal

Add-on software to DXA scanners for assessment of trabecular bone quality

Overview

Add-on software to DXA scanners for assessment of trabecular bone quality. The company has developed software for medical technologies to assess the quality of the trabecular bone. The FDA-cleared (K152299)TBS iNsight is a software that installs on any DXA scanners, which estimates the fracture risk based on a determination of bone texture, in addition to risks determined by DXA bone mineral density and clinical risk factors. The result is expressed as a Trabecular Bone Score (TBS).

Key facts

Founded
2006

Business model

Contact

Open roles

1 role
  • Event Specialist

    Texas, United States · Hybrid · Full-time

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Digital case scheduling for anesthesiologists

    Health TechnologyLos Angeles, United States
  • Provider of tool for drug testing services in laboratories

    Health TechnologyLittle Rock, United States

About Medimaps Group

What does Medimaps Group do?

Add-on software to DXA scanners for assessment of trabecular bone quality.

Where is Medimaps Group headquartered?

Medimaps Group is headquartered in Wilmington, United States.

When was Medimaps Group founded?

Medimaps Group was founded in 2006.

Which sector is Medimaps Group in?

Medimaps Group operates in Health Technology.

Who are Medimaps Group's competitors?

Companies similar to Medimaps Group include AnesthesiaGo, PinPoint Testing, and Portford Solutions Group.

Is Medimaps Group hiring?

Yes. Medimaps Group has 1 open role listed on Vanberra Signal.